Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associated neurocognitive disease (HAND)

HIV-associated neurocognitive disorders (HAND) continues to be prevalent (30–50 %) despite plasma HIVRNA suppression with combination antiretroviral therapy (cART). There is no proven therapy for individuals on suppressive cARTwith HAND. We have shown that the degree of HIV reservoir burden (HIV DNA...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Neurovirol
Autori principali: Ndhlovu, Lishomwa C., Umaki, Tracie, Chew, Glen M., Chow, Dominic C., Agsalda, Melissa, Kallianpur, Kalpana J., Paul, Robert, Zhang, Guangxiang, Ho, Erika, Hanks, Nancy, Nakamoto, Beau, Shiramizu, Bruce T., Shikuma, Cecilia M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2014
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4268390/
https://ncbi.nlm.nih.gov/pubmed/25227930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13365-014-0279-x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi